These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15238200)

  • 1. Delayed Gastric Emptying in Functional Dyspepsia.
    Stanghellini V; De Giorgio R; Barbara G; Cogliandro R; Tosetti C; De Ponti F; Corinaldesi R
    Curr Treat Options Gastroenterol; 2004 Aug; 7(4):259-264. PubMed ID: 15238200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the treatment of functional dyspepsia.
    Stanghellini V; De Ponti F; De Giorgio R; Barbara G; Tosetti C; Corinaldesi R
    Drugs; 2003; 63(9):869-92. PubMed ID: 12678573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].
    Serra J
    Gastroenterol Hepatol; 2010 Oct; 33(8):586-90. PubMed ID: 20850200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F; Tonini M
    Drugs; 2001; 61(3):317-32. PubMed ID: 11293643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional dyspepsia: drugs for new (and old) therapeutic targets.
    Cremonini F; Delgado-Aros S; Talley NJ
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):717-33. PubMed ID: 15324710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and emerging treatments for irritable bowel syndrome and functional dyspepsia.
    Talley NJ
    Expert Opin Emerg Drugs; 2002 May; 7(1):91-8. PubMed ID: 15989538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.
    Arts J; Caenepeel P; Verbeke K; Tack J
    Gut; 2005 Apr; 54(4):455-60. PubMed ID: 15753526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional dyspepsia: a pragmatic approach.
    Giurcan R; Voiosu TA
    Rom J Intern Med; 2010; 48(1):9-15. PubMed ID: 21180236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional dyspepsia].
    Feinle C; Fried M
    Ther Umsch; 1997 Nov; 54(11):629-34. PubMed ID: 9454364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional dyspepsia.
    Enck P; Azpiroz F; Boeckxstaens G; Elsenbruch S; Feinle-Bisset C; Holtmann G; Lackner JM; Ronkainen J; Schemann M; Stengel A; Tack J; Zipfel S; Talley NJ
    Nat Rev Dis Primers; 2017 Nov; 3():17081. PubMed ID: 29099093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
    Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
    Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying].
    Portincasa P; Mearin F; Robert M; Plazas MJ; Mas M; Heras J
    Gastroenterol Hepatol; 2009 Dec; 32(10):669-76. PubMed ID: 19819042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Developments in Prokinetic Therapy for Gastric Motility Disorders.
    Camilleri M; Atieh J
    Front Pharmacol; 2021; 12():711500. PubMed ID: 34504426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome.
    van der Voort IR; Osmanoglou E; Seybold M; Heymann-Mönnikes I; Tebbe J; Wiedenmann B; Klapp BF; Mönnikes H
    Neurogastroenterol Motil; 2003 Oct; 15(5):467-73. PubMed ID: 14507348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic and clinical pharmacology of new motility promoting agents.
    Galligan JJ; Vanner S
    Neurogastroenterol Motil; 2005 Oct; 17(5):643-53. PubMed ID: 16185302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of levosulpiride on gastric and gall-bladder emptying in functional dyspepsia.
    Arienti V; Corazza GR; Sorge M; Boriani L; Ugenti F; Biagi F; Maconi G; Sottili S; Van Thiel DH; Gasbarrini G
    Aliment Pharmacol Ther; 1994 Dec; 8(6):631-8. PubMed ID: 7734028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorders of gastric emptying].
    Jian R
    Presse Med; 1992 Jun; 21(23):1072-8. PubMed ID: 1387939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.